TETRAMETHYLDECANEDIOL
General Information
Mainterm | TETRAMETHYLDECANEDIOL |
CAS Reg.No.(or other ID) | 1322-75-4 |
Regnum |
175.105 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 53735698 |
IUPAC Name | 3,3,4-trimethylundecane-2,2-diol |
InChI | InChI=1S/C14H30O2/c1-6-7-8-9-10-11-12(2)13(3,4)14(5,15)16/h12,15-16H,6-11H2,1-5H3 |
InChI Key | CQZXCLFDXWOTOC-UHFFFAOYSA-N |
Canonical SMILES | CCCCCCCC(C)C(C)(C)C(C)(O)O |
Molecular Formula | C14H30O2 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 230.392 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 8 |
Complexity | 185.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A D w S A g A A C C A A A A g A A A A A A A A A A A A A A A A A A A A A A A A A A A A I A A A A A Q A A E A A A A A A G A w O A P g A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 40.5 |
Monoisotopic Mass | 230.225 |
Exact Mass | 230.225 |
XLogP3 | None |
XLogP3-AA | 5.0 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 16 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9430 |
Human Intestinal Absorption | HIA+ | 0.9076 |
Caco-2 Permeability | Caco2+ | 0.6635 |
P-glycoprotein Substrate | Substrate | 0.5000 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9548 |
Inhibitor | 0.5871 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9124 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5666 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7811 |
CYP450 2D6 Substrate | Non-substrate | 0.8747 |
CYP450 3A4 Substrate | Non-substrate | 0.5160 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6713 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7697 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9086 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8503 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8975 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7960 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9671 |
Non-inhibitor | 0.8281 | |
AMES Toxicity | Non AMES toxic | 0.9373 |
Carcinogens | Carcinogens | 0.5562 |
Fish Toxicity | High FHMT | 0.8628 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9531 |
Honey Bee Toxicity | High HBT | 0.7329 |
Biodegradation | Not ready biodegradable | 0.6948 |
Acute Oral Toxicity | III | 0.7732 |
Carcinogenicity (Three-class) | Non-required | 0.7220 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.4731 | LogS |
Caco-2 Permeability | 0.8018 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.0852 | LD50, mol/kg |
Fish Toxicity | 2.0171 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.1776 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Alcohols and polyols |
Intermediate Tree Nodes | Not available |
Direct Parent | Carbonyl hydrates |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Carbonyl hydrate - Hydrocarbon derivative - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as carbonyl hydrates. These are organic compounds containing two hydroxyl groups attached to a carbon atom. |
From ClassyFire